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We evaluated 76 adenovirus type 7 (Ad7) isolates col-
lected in Iowa from 1992 to 2002 and found that genome
type Ad7d2 became increasingly prevalent. By 2002, it had
supplanted all other Ad7 genome types. The association of
Ad7d2 with severe illness and death calls for heightened
public health concern.
H
uman adenoviruses are the cause of a wide spectrum
acute and chronic diseases. The associations of aden-
ovirus with keratoconjunctivitis, upper respiratory tract
infections, pneumonia, gastroenteritis, cystitis, and
encephalitis have long been recognized. Recently, molecu-
lar methods have shown adenoviruses to be associated
with bronchopulmonary dysplasia (1), chronic obstructive
pulmonary disease (2), and mycocarditis (3). Adenovirus
infections cause severe illness and death in immunocom-
promised persons, particularly bone marrow transplant
recipients (4–6).
In 2002, Erdman et al. (7) reported that 2 emergent
genome types of adenovirus type 7 (Ad7) had recently been
detected in North American populations. From restriction
enzyme studies of 166 archived specimens, the available
data suggested that Ad7d2 and Ad7h first appeared in North
America in 1993 and 1998, respectively. Both genome
types had been associated with epidemics, severe illness,
and deaths in populations outside the United States. Since
Ad7d2 has been associated with 3 military and 3 civilian
epidemics and at least 19 deaths in the United States since
1993, the 2002 report voiced concern regarding a shift in
the prevalence of U.S. adenovirus strains and the need to
increase surveillance for adenoviral disease. We present a
retrospective study of Ad7 isolates in Iowa.
The Study
By using a previously described DNArestriction analy-
sis procedure (7), we studied 76 archived adenovirus iso-
lates collected among influenzalike-illness surveillance
sites across Iowa from 1992 to 2002.
Among the 76 isolates, 40 (53%) were Ad7d2, and 6
(8%) were Ad7h (Figure). The first Ad7d2 specimen was
isolated in March 1994 from a child living in south-central
Iowa. The first Ad7h specimen was isolated in November
1993 from a child living in north-central Iowa. The latter
specimen is the earliest Ad7h detected in North America. 
Ad7d2 caused illness among patients in Iowa ranging
in age from 3 months to 49 years. Of the patients, 75%
were male (cause of overrepresentation is unknown).
Although the clinical details are sparse, a number of
patients were thought to have influenza or were diagnosed
with respiratory distress syndrome. At least 4 children
from an Ad7d2 October 2000 epidemic at a long-term care
facility in Des Moines, Iowa, died. Ad7d2 isolates were
obtained from 12 different sites in Iowa. Ad7h was detect-
ed in 4 Iowa counties. 
Beginning in 1994, Ad7d2 became increasingly more
prevalent across Iowa, displacing Ad7b, the predominant
genome type circulating in the United States since the
early 1970s (8). In 2002, data suggest that Ad7d2 supplant-
ed all other Ad7 genome types (9 of 9 Ad7 isolates were
A7d2) (Figure).
Conclusions
Ad7d2 and Ad7h have only recently been recognized.
Ad7d2 was first detected in Israel in 1992; beginning in
1995, it was associated with epidemics of unusually severe
respiratory disease with high fevers among children in
Japan (9,10). Ad7h was first detected in South America in
1986; since then it has supplanted the previous most preva-
lent genome type, Ad7c, in Chile, Uruguay, Argentina, and
possibly other countries (11). Ad7h has caused pediatric
respiratory epidemics, and infected children had longer
hospitalizations, had higher temperatures, and required
more supplemental oxygen (12). In at least 1 study, up to
94% of adenovirus deaths were attributed to Ad7h (11).
Whether these strains are truly more virulent or whether
they better evade the host’s immune system is a matter for
future study. What does seem to be clear is that a simple
mutation (Ad7d2) (9) or recombination (Ad7h) (13) may
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Figure. Number of adenovirus (Ad) isolates collected in Iowa dur-
ing influenzalike illness surveillance by genome type and year.generate new adenovirus strains that could result in more
epidemics and higher death rates. These strains may then
quickly migrate to new areas and cause more epidemics. 
Current U.S. surveillance for adenovirus is passive and
incomplete. The number of immunocompromised patients
in the United States is increasing, and they, in addition to
young children, may be at increased risk for severe disease
from emergent adenovirus strains. Developing molecular
typing strategies for emerging Ad strains seems prudent, as
does improving local and national surveillance for aden-
ovirus illness. Considering adenovirus to be a potential
nosocomial pathogen seems wise, and researchers should
seek to identify effective antiviral therapy for outbreak
interventions. These actions will help public health offi-
cials better understand the changing epidemiology of ade-
novirus infections. Because of increased adenovirus
morbidity (14,15), the U.S. Department of Defense recent-
ly contracted to again produce Ad4 and Ad7 vaccines for
military trainees. If civilian populations were identified to
be at high risk for serious Ad4 or Ad7 disease, they might
also benefit from these vaccines.
This study was funded by the University of Iowa. A prelim-
inary report of this work was presented at the International
Conference on Emerging Infectious Diseases held in Atlanta,
Georgia, during February 29 through March 3, 2004.
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